GLAND PHARMA
Back to Income Statement
|
GLAND PHARMA Last 5 Year Total Expenditure History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Expenditure | ₹4,332 Cr | ₹2,600 Cr | ₹2,891 Cr | ₹2,161 Cr | ₹1,678 Cr |
What is the latest Total Expenditure of GLAND PHARMA ?
| Year | Total Expenditure |
|---|---|
| Mar2025 | ₹4,332 Cr |
| Mar2024 | ₹2,600 Cr |
| Mar2023 | ₹2,891 Cr |
| Mar2022 | ₹2,161 Cr |
| Mar2021 | ₹1,678 Cr |
How is Total Expenditure of GLAND PHARMA Trending?
| Years | Total Expenditure | % Change | |
|---|---|---|---|
| Mar2025 | ₹4,332 Cr | 66.61 | |
| Mar2024 | ₹2,600 Cr | -10.06 | |
| Mar2023 | ₹2,891 Cr | 33.78 | |
| Mar2022 | ₹2,161 Cr | 28.78 | |
| Mar2021 | ₹1,678 Cr | - | |
Compare Total Expenditure of peers of GLAND PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| GLAND PHARMA | ₹28,162.7 Cr | 7% | -5.2% | 5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹430,645.0 Cr | 2.9% | 3.6% | 0.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹159,625.0 Cr | 0.6% | -4.5% | 3.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹145,415.0 Cr | 2.1% | -0.4% | 31.8% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹108,664.0 Cr | 2.2% | -0.4% | 6.2% | Stock Analytics | |
| CIPLA | ₹100,480.0 Cr | 0.4% | -6.2% | -19.4% | Stock Analytics | |
GLAND PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| GLAND PHARMA | 7% |
-5.2% |
5% |
| SENSEX | -1.9% |
-9.1% |
-0.2% |
You may also like the below Video Courses